Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Current Opinion in Neurology|April 14, 2021
Drug interactions and risks associated with the use of triptans, ditans and monoclonal antibodies in migraineLinda Al-Hassany, Antoinette MaassenVanDenBrink
Frontiers in Neurology|April 7, 2025
Sex-related differences in the association between migraine, COVID-19, and long COVID: a population-based cohortLinda Al-Hassany, Antoinette MaassenVanDenBrink, Tobias Kurth
JAMA Network Open|October 22, 2024
Cardiovascular Risk Scores and Migraine StatusLinda Al-Hassany, Antoinette MaassenVanDenBrink, Tobias Kurth
Expert Opinion on Pharmacotherapy|March 2, 2021
Evaluating rimegepant for the treatment of migraineTessa de Vries, Linda Al-Hassany, Antoinette MaassenVanDenBrink
Frontiers in Neurology|June 28, 2021
Metabolic Aspects of Migraine: Association With Obesity and Diabetes MellitusEduardo Rivera-Mancilla, Linda Al-Hassany, Carlos M Villalón, et al.
Patient Preference and Adherence|August 16, 2019
Assessing methods of measuring medication adherence in chronically ill children-a narrative reviewLinda Al-Hassany, Sanne M Kloosterboer, Bram Dierckx, et al.
Cephalalgia : an International Journal of Headache|August 18, 2021
Could erectile dysfunction be a side effect of CGRP inhibition? A case reportLinda Al-Hassany, Tessa de Vries, Johannes A Carpay, et al.
The Lancet. Neurology|January 30, 2022
Calcitonin gene-related peptide-targeting drugs for migraine: how pharmacology might inform treatment decisionsLinda Al-Hassany, Peter J Goadsby, A H Jan Danser, et al.
Neurology|July 31, 2024
Sex-Specific Association of Cardiovascular Risk Factors With Migraine: The Population-Based Rotterdam StudyLinda Al-Hassany, Cevdet Acarsoy, M Kamran Ikram, et al.
Pageof 3